How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care ...

Tempus AI (TEM) may be building one of healthcare's fastest-growing artificial intelligence (AI) platforms, but the stock ...

Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to ...

Tempus peers such as Inspire Medical Systems INSP and 10x Genomics TXG are also expected to maintain growth momentum heading ...

Tempus AI approaches workload and work-life balance by providing flexibility where possible, supporting employee wellbeing through comprehensive benefits, fostering a collaborative team environment, ...

Awesome. Well, I appreciate everyone being here. I'm Matt Strom, Morgan Stanley Investment Banking. I lead the health care data and AI practice. Great to see you all and great to have Eric with Tempus ...

Investors with a lot of money to spend have taken a bullish stance on Tempus AI (NASDAQ:TEM). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Inaugural program provides unprecedented access to Tempus’ library of de-identified multimodal data and models, scalable compute infrastructure and direct funding to catalyze clinical and technical ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to ...